Equine Insulin Testing | In-House Horse Insulin Test

Quantitative equine insulin testing for veterinary practice. Support investigation of insulin dysregulation, metabolic disease and laminitis risk with the BIODX HV-FIA 3000.

Shop

Equine Insulin Test

$0.00

Availability: Out of stock

Benefits

Quantitative Point-of-Care


Quantitative equine insulin testing on a compact veterinary immunofluorescence platform.

Investigate Metabolic Health


Designed to support investigation of insulin dysregulation and equine metabolic health.

Objective Information


Useful when clinical signs, body condition, and metabolic risk require objective laboratory information.

Compact & Multi-Assay


Small, compact analyser supporting insulin, SAA, ACTH, Foal IgG, and progesterone on one platform.

WHAT IS INSULIN?


Insulin is a hormone produced by the pancreas that plays a central role in regulating blood glucose and energy metabolism. In horses, abnormal insulin regulation can be clinically important, particularly in animals with metabolic risk factors.
Insulin results should be interpreted together with the horse's history, body condition, diet, clinical findings and the specific testing protocol used. A single insulin result should not be treated as a diagnosis by itself.
Request a Quote
insulin dysregulation horse

WHY TEST INSULIN IN HORSES?


Equine insulin testing can provide objective information when a veterinarian is investigating possible insulin dysregulation or metabolic disease. It may be particularly relevant when a horse has clinical or management features associated with metabolic risk.

• Investigation of suspected insulin dysregulation.
• Support for assessment of horses at risk of equine metabolic syndrome (EMS).
• Assessment of metabolic status in horses with a history or risk of laminitis.
• Investigation of abnormal body condition or regional adiposity in an appropriate clinical context.
• Monitoring selected horses as part of a broader management and veterinary plan.
• Providing quantitative information alongside clinical examination and other diagnostic findings.

WHY BRING EQUINE INSULIN TESTING IN-HOUSE?

Reduce dependence on sending every metabolic question to an external laboratory, where appropriate.

Support a more responsive workflow when clinical decisions require quantitative information.

Keep testing within the veterinary practice workflow.

Use the same FIA platform for multiple equine biomarkers rather than purchasing a separate analyser for every test.

Support client communication by linking the quantitative result with the horse's clinical assessment.

horse insulin testing

The BIODX HV-FIA 3000 supports quantitative equine insulin testing as part of its equine immunoassay menu.


• Equine insulin (eINS) assay.
• BIODX specification: 75 μL sample volume.
• BIODX specification: approximately 15-minute reaction/test time for eINS.
• Intended clinical application stated by the BIODX: insulin dysregulation, EMS, laminitis risk and PPID suspicion.
• Use the current Australian assay IFU for specimen requirements, preparation, storage, reference information and final reporting requirements.

FROM SAMPLE TO RESULT

Clinical question

Identify why insulin testing is being performed

Select protocol

Choose the appropriate resting or dynamic testing approach

Collect sample

Follow the current assay/protocol requirements

Prepare sample

Process according to the current IFU

Run the test

Load the prepared sample into the FIA workflow

Quantitative result

Review the result with the clinical history and testing protocol

Clinical interpretation

Determine next steps as part of the overall veterinary assessment

ONE ANALYSER. MORE EQUINE QUESTIONS

The HV-FIA 3000 can support a broader equine testing workflow beyond insulin, subject to the current available assay menu.

Equine Insulin

eINS

Equine Serum Amyloid A

eSAA

Passive transfer assessment

Foal IgG

Equine ACTH

eACTH

Equine Progesterone

eProg

EQUINE METABOLIC SYNDROME — WHERE INSULIN FITS

Equine metabolic syndrome is a clinical concept involving metabolic abnormalities and an increased risk of laminitis. Insulin dysregulation is an important component of the assessment, but diagnosis and risk assessment require more than a single insulin measurement.

  • Clinical examination and history
  • Body condition and regional fat distribution
  • Laminitis history and current foot health
  • Diet and management review
  • Appropriate insulin testing protocol
  • Additional testing when clinically indicated

FASTING, BASAL AND DYNAMIC TESTING

Different insulin testing approaches answer different clinical questions. Depending on the case, a veterinarian may use a resting/basal measurement or a controlled dynamic testing protocol. Dynamic testing can be useful when the clinical question is specifically about the horse's insulin response.

The exact protocol, feeding instructions, sampling schedule and interpretation criteria should follow the veterinarian's chosen validated protocol and the current assay/laboratory guidance.

TESTING PROTOCOL MATTERS


Equine insulin results can be influenced by pre-analytical and physiological factors. For that reason, the veterinarian should select and follow an appropriate testing protocol rather than interpreting every insulin result in the same way.
• Document the horse's recent feeding and management.
• Use the sampling protocol appropriate to the clinical question.
• Handle and process the specimen according to the current assay instructions.
• Record relevant clinical and dietary information with the result.
• Interpret against the appropriate laboratory/assay guidance rather than applying an unsupported universal cut-off.

INSULIN DYSREGULATION AND LAMINITIS RISK

Insulin dysregulation is clinically relevant in equine metabolic health because abnormal insulin responses are associated with increased risk of endocrinopathic laminitis. Testing can therefore be one component of a broader veterinary assessment of a horse with suspected metabolic risk.

Technical Specifications

Test Equine Insulin (eINS)
Platform BIODX / Healvet HV-FIA 3000 Veterinary Immunofluorescence Analyser
Sample volume 75 μL — manufacturer brochure specification
Test/reaction time Approximately 15 minutes — manufacturer brochure specification
Clinical applications stated Insulin dysregulation, EMS, laminitis risk, PPID suspicion
Specimen requirements Follow current Australian eINS IFU
Reference interval / cut-off Follow current assay-specific and protocol-specific guidance
Interpretation Veterinary clinical interpretation required

Local Support. Veterinary Focus. Real Diagnostic Capability

YOU BUY THE ANALYSER. BIODX HELPS YOU MAKE IT WORK IN PRACTICE.

Australian Veterinary Supplier

Headquartered in Liverpool, NSW, providing localized customer support and rapid consumable dispatch across Australia.

Application Guidance

Direct assistance selecting test profiles matched to small animal, equine, exotics, or mixed clinical caseloads.

Ongoing Technical Service

Dedicated technical support and account managers to ensure high uptime and long-term diagnostic confidence.

Bring Equine Metabolic Testing Closer to the Horse


Explore quantitative equine insulin testing with the BIODX HV-FIA 3000.